Hormone Replacement Therapy (HRT), commonly used to relieve menopausal symptoms, can also affect cancer risk. Combined HRT (estrogen and progesterone) has been linked to an increased risk of breast cancer, whereas estrogen-only HRT can increase the risk of endometrial cancer in women with an intact uterus. The risks and benefits of HRT should be carefully evaluated by a healthcare professional.
